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Abstract
Objective: Life expectancy of cryopreserved allografts implanted in infants is different from those implanted in adults. A morphological
study of explanted allograft heart valves was performed to determine the mechanism of deterioration and to compare cryopreserved arterial
and heart valve allografts from adult patients with those explanted from infants. Method: Between 1987 and 1996, 209 cryopreserved
allografts were implanted: 125 valved conduits or monocusps to reconstruct the right ventricular outflow tract in congenital heart disease,
50 allograft heart valves to treat native aortic and prosthetic aortic valve endocarditis and 34 cryopreserved arterial allografts to replace
mycotic aortic aneurysms or infected aortic prosthetic grafts. Two months to 8 years after implantation, 23 heart valve allografts, 11 right-
sided and 12 left-sided, and four arterial allografts had to be explanted for reasons such as degeneration, recurrent infection, aneurysm
formation or rupture. Besides conventional staining, immunohistochemical detection of cell populations was performed as follows:
CD45RO, CD3 and CD43 for T lymphocytes, CD20 for B lymphocytes, CD68 for macrophages, protein S100 for Langerhans-cells,
vimentin for fibroblasts, a-actin for smooth muscle cells and factor VIII for endothelial cells. Results: Explanted cryopreserved allografts
were all fibrotic, acellular, non-vital and without endothelial cells. The fibrous tissue was preserved. T lymphocytes, indicating rejection,
were found in all right-sided allografts from the paediatric population, but only in 9% of left-sided valves explanted from adults and in one
of the four of arterial allografts. Macrophages and Langerhans-cells were found only in right-sided allografts from paediatric patients.
Conclusion: Right-sided cryopreserved allografts from a paediatric population showed ongoing cellular rejection. By contrast, there was
only a weak T-cell mediated rejection to adult heart valve and arterial allografts. Therefore, similar long-term results can be expected in
adult arterial and heart valve allografts, whereas longevity of right-sided heart valve allograft in the paediatric age group seems endangered
by cellular rejection. Ó 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Despite the changing methods of procurement and var-
ious sterilization protocols such as gamma irradiation, pre-
treatment with glutaraldehyde or dry-freezing, a durable
cardiovascular allograft has not yet been found.
The cryopreservation of heart valves has been reported to
result in a viable allograft capable of maintaining its col-
lagenous matrix by constant self-repair resulting in a dur-
able homologous heart valve substitute [1]. The presence of
a variable degree of cellularity, the ability to metabolize
glucose and the successful culture of fibroblasts from ex-
planted cryopreserved heart valve allografts was thought to
indicate preserved viability late after implantation [2]. In
fact, valve leaflet tissue from an aortic allograft, explanted
up to 10 years after implantation was considered as viable
due to the presence of intact donor fibroblasts, identified by
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DNA fingerprint studies [3]. Thus, viability seems to confer
durability on allograft valves.
However, the degree of antigen expression is determined
by the viability of the allograft and especially of the allo-
graft endothelial cells which are able to express class I and
class II major histocompatibility antigens [4]. Allografts
that are used to reconstruct the right ventricular outflow
tract in congenital cardiac surgery are much more prone
to degeneration compared with allograft heart valves
implanted in the adult left ventricular outflow tract [5].
Thus, durability of the allograft seems to be determined
by its antigenicity and by the degree of the immunological
response of the host; the latter seems to be stronger in
infants than in adults.
In this report, results from morphological and immuno-
histochemical examinations performed in cryopreserved
allografts explanted from the right ventricular outflow
tract, from the left ventricular outflow tract and from
explanted cryopreserved arterial allografts were compared
between adult patients and patients from a paediatric age
group. The purpose of the present study was, first, to deter-
mine the viability of explanted allografts; second, to eluci-
date the question, if early allograft degeneration is
paralleled by an active immunological rejection; third, to
identify differences in the rejection reaction on implanted
allografts between infants and adults; and fourth, to evaluate
the immunological reaction on arterial allografts to predict
the long-term behaviour of implanted arterial allografts
comparing the immune response of arterial and heart
valve allografts.
2. Materials and methods
2.1. Patients
Morphological and immunohistochemical examinations
were performed on 27 explanted cardiovascular allografts,
11 heart valve allografts from the right ventricular outflow
tract in infants, aged 2–16 years, 12 heart valve allografts
from the left ventricular outflow tract in adults and four
arterial allografts from the infrarenal aorta and pelvic ves-
sels.
The 11 right ventricular to pulmonary artery allografts,
valved conduits and monocusps, were explanted 2 weeks–7
years after implantation [6]. Reasons for explantation were:
monocusp patch regurgitation 2 weeks after implantation in
one, marked aneurysm formation of a valved allograft in
two, heart transplantation 5 years after total correction for
double-outlet right ventricle in another child and calcifying
allograft stenosis at the distal anastomosis to the native
pulmonary artery in five and along the conduit in the
remaining two children. Thus, 9% of right-sided allografts
had to be replaced during this 9-year observation period.
Besides, the reoperative mortality rate was 0%.
Twelve left-sided heart valve allografts, used to treat
acute infectious endocarditis [7], had to be replaced 4
weeks–8 years after implantation. Reasons for reoperation
were: allograft endocarditis in three, allograft degeneration
in five, pseudoaneurysm formation causing allograft regur-
gitation in three patients and recurrent mitral valve regur-
gitation in one. During the observation period, the
reoperation rate for allografts, used to treat acute destructive
aortic root endocarditis was 24% with a reoperative mortal-
ity rate of 8% due to a fatal perioperative neurological event
in one patient.
Since 1990, cryopreserved arterial allografts were
increasingly used to treat mycotic aortic aneurysm and pros-
thetic aortic graft infection [8]. Four out of 34 implanted
arterial allografts (12%), removed at the time of autopsy,
were available for morphological and immunohistochemi-
cal examination: one patient died from a sudden cardiac
death early postoperatively, one from multi-organ failure
due to multiple intraabdominal abscesses after perforation
of the sigmoid colon with faecal peritonitis and two died late
from allograft-enteric fistulae 10 and 18 month after implan-
tation.
2.2. Methods
2.2.1. Histology
Intraoperatively, the allografts were macroscopically
evaluated and carefully removed. After immersion fixation
(paraformaldehyde/glutaraldehyde/picric acid), Paraffin
sections were cut and stained with Haematoxylin-Eosin
and the elastin van Gieson method. In case of suspected
recurrent endocarditis or persistent vascular infection, peri-
graft exudates and tissue specimens were sent to microbio-
logical examinations. Rapid Gram’s staining and
examination for aerobes and anaerobes and fungi were per-
formed. In addition, polymerase chain reaction (PCR) was
used to identify the responsible infectious agents.
2.2.2. Immunohistochemistry
Immunohistochemical studies using an immunoperoxi-
dase method were performed on all allografts. For the iden-
tification of inflammatory cells the following antibodies
were used: CD20 for B lymphocytes, CD45RO, CD3 and
CD43 for T lymphocytes and CD68 for macrophages.
Monoclonal antibodies against alpha actin were used to
identify muscle cells, anti-S100 protein was used to detect
infiltration of antigen-presenting cells. Anti-vimentin detec-
ted fibroblasts and anti-factor VIII identified endothelial
cells on the luminal surface of allografts.
3. Results
3.1. Macroscopy
Allografts explanted from infants showed extensive, cir-
cumferential calcification of the allograft wall. If allograft
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stenosis was the reason for reoperation, then it was found at
the distal anastomosis from the allograft to the native pul-
monary artery bifurcation. Proximal, infundibular or valvu-
lar allograft stenosis was not observed. Surprisingly, the
valve leaflets, either from valved allografts or from mono-
cusps, were delicate, mobile and seemed to be spared from
the calcifying process. In one child, a true aneurysm of the
entire allograft was found intraoperatively causing severe
pulmonary valve regurgitation. Due to the small number of
patients, we did neither expect nor find any difference
between pulmonary and aortic allografts with regard to
long-term function or degree of degeneration.
Similar intraoperative findings were observed in the left
ventricular outflow tract from adult patients although the
degree of calcification was less with spotty calcifications
observed in the aortic root and allograft wall. The leaflets
were delicate and not involved in the degenerative allograft
process. In case of recurrent endocarditis, leaflets were
destroyed similar to the acute infection of the native aortic
valve. Annular abscesses or allograft-ventricular disconnec-
tion was not found. In three patients, originally operated
with the scalloped-freehand implantation technique, pseu-
doaneurysm formation distorting the geometry of the aortic
root, led to compression of the allograft and subsequent
regurgitation.
Results from explanted cryopreserved arterial allografts
are scarce and were all found at autopsy. In three patients, an
allograft-enteric fistula was found, originating from a small
allograft side-branch artery. The distal and proximal anasto-
moses were found to be normal except in one patient with a
leakage of the proximal infrarenal anastomosis of a bifurca-
tion allograft due to persistence of Candida albicans infec-
tion (Fig. 1). Dilatation or calcification of arterial allografts
was not found.
3.2. Histology
Explanted allografts, heart valves and arteries, were
almost acellular in the media with only few donor fibro-
cytes. The lamina elastica showed partial fragmentation
and total desquamation of the endothelial layer. A dense
fibrous band, a neointima, was observed on the luminal sur-
face of the allograft wall.
The interface between the allograft and the native tissue
was fused containing few fibrocytes, smooth muscle cells,
collagen and elastic fibers. Host fibroblasts and monocytes
seemed to invade the allograft at the interface from the
adventitial layer giving the impression of a localized inflam-
matory reaction. In case of endocarditis, significant inflam-
matory cell infiltration was found and Gram staining
revealed gram-positive bacteria in one patient.
The leaflets showed plasma and fibrin insudation but were
acellular and, in infants as well as in adults, free from any
inflammatory cell infiltration. In addition, calcification was
not found in allograft valve leaflets. By contrast, the wall of
the heart valve allograft was heavily calcified. In adults,
spotty calcifications were noted, however in children, cir-
cumferential calcifications as soon as 18 months after
implantation and even bone formation was observed.
Light microscopy demonstrated a preserved structure of
the matrix constituents, especially the collagenous frame-
work and the glycosaminoglycane content, in heart valve as
well as in arterial allografts. Besides, arterial allografts,
although with a shorter follow-up, were free from any cal-
cifications.
3.3. Immunohistochemistry
Multiple foci of inflammatory infiltration were found in
the wall of allografts explanted from the paediatric popula-
tion. They were made up predominantly from T lympho-
cytes (Fig. 2), indicating active, ongoing allograft rejection.
B lymphocytes were sparse. In older allografts, positive
staining reactions with CD68 and S100 revealed the pre-
sence of macrophages and some antigen-presenting cells.
In addition multiple foci of plasma cell infiltration were
found as well (Fig. 3).
By contrast, allografts from the left ventricular outflow
tract in adults were free from T lymphocytes except in one
Fig. 1. Infrarenal anastomotic leakage of a cryopreserved aorto-bifemoral
bifurcation allograft with persistence of Candida albicans infection.
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patient who died after several aortic root reoperations
caused by an unidentified destructive process, which
affected every type of valve replacement device. Macro-
phages and antigen-presenting cells could not be found in
allografts explanted from adults and B lymphocytes were
sparse and only in the wall of the valved allograft. Neutro-
phils, macrophages and lymphocytes were not found in the
allograft valve leaflets.
Results for arterial allografts were similar to explanted
left-sided allografts. In general, inflammatory cell infiltra-
tion was limited and T lymphocytes were found only in one
short iliac segment of an aorto-biiliac bifurcation graft,
implanted for a huge right retroperitoneal abscess after pros-
thetic graft infection with Aspergillus fumigatus, Candida
albicans and Staphylococcus aureus.
4. Discussion
The results of the present study demonstrate an almost
complete loss of cellular elements and a total desquamation
of endothelial cells in cryopreserved cardiovascular allo-
grafts explanted form infants and adults. Furthermore, an
active T lymphocyte mediated rejection, as well as macro-
phages and antigen-presenting cells have been found in the
wall of the allografts used to reconstruct the right ven-
tricular outflow tract in congenital heart disease. By con-
trast, explanted allografts from the left ventricular outflow
tract, used to treat acute infective endocarditis in adult
patients, showed a limited humoral rejection with only
few B lymphocytes in the wall of the allograft. Macro-
phages and antigen-presenting cells were not observed.
Inflammatory cell infiltration was not found in the valve
leaflets neither in heart valve allografts from adults nor
from infants.
The ideal cardiovascular conduit has not yet been found
for the use in children. This is especially true for the ven-
tricular to pulmonary artery connection, the last durable part
of an otherwise successful biventricular repair. The use of
cryopreserved allografts facilitated reconstruction of the
right ventricular outflow tract and a lower overall mortality
has been observed with its use [9]. However, the freedom
from allograft-related reoperation has not improved and
allograft replacement is inevitable [10]. Inflammatory infil-
Fig. 2. Immunohistochemical stain for CD3 demonstrating T lymphocyte
infiltration in a 2-year-old aortic allograft from right ventricular outflow
tract (original magnification · 300).
Fig. 3. Plasma cell infiltration in a 4-year-old pulmonary allograft from the
right ventricular outflow tract (Haematoxylin-Eosin; original magnification
· 300).
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tration of T lymphocytes altering tissue structure and func-
tion, is the major finding in our explanted allografts from the
paediatric age group and is accepted as active rejection. The
presence of B lymphocytes, macrophages, antigen-present-
ing cells and plasma cell infiltration completes the impres-
sion of a strong and continuous immunological response to
the allografts implanted in children, decreasing its life
expectancy considerably. In addition, the right-sided allo-
graft stenosis observed at the distal anastomoses from the
allograft to the native pulmonary bifurcation was caused by
extensive and circumferential calcification, preventing ade-
quate growth even of the adjacent native tissue.
By contrast, allografts from the left ventricular outflow
tract from adult patients showed only a weak immunological
reaction. B lymphocyte infiltration was weak and macro-
phages, antigen-presenting cells and T lymphocytes were
absent except in one patient. This is an interesting find-
ing, as these allografts, used to treat destructive infectious
endocarditis [7], were placed into an immunologically up-
regulated environment. However, the adult host’s immuno-
logical response to these left-sided allografts was weak,
partially contributing to the long-term allograft durability
in adults.
Besides the rejection reaction of the host, the preserved
viability of allografts has been thought to confer durability
[11]. However, our explanted cryopreserved allografts were
almost acellular and without endothelial cells and we con-
sidered all as non-viable. This loss of viability has been
confirmed by others [12] and human valves prepared for
use as allografts have found to be non-viable even before
implantation [13]. Cryopreservation, on the other hand,
represents a cell- and tissue-protective preparation method
[14], preserving the collagenous skeleton and the ground
substance, rendering the allograft relatively immunologi-
cally inert and mechanically superior to freshly implanted
allografts [15]. We believe, that the preservation of the col-
lagenous network and not the presumed viability improves
the durability of cryopreserved allografts.
The degree of the rejection reaction observed in infants,
however, is more important in determining the durability of
allografts than the preservation of the ground substance and
this seems to be confirmed by the rather limited life expec-
tancy of allografts implanted in the immunologically active
paediatric age group [16]. This interpretation is supported
by another study, observing the same predominant T lym-
phocyte infiltration in allograft cardiac valves in infants
[17] and further by the fact, that donor-specific T lympho-
cytes can be cultivated from explanted allografts [18]. By
contrast, compared with the relatively weak rejection reac-
tion of the adult host, the preservation of the collagen ske-
leton seems to be more important in determining the long-
term durability of left-sided allografts in adult patients
[19,20].
The results with allografts in the treatment of infective
endocarditis stimulated the use of arterial allografts for the
treatment of major vascular infection. Although early results
are satisfactory [8], the long-term behaviour of these grafts
is unknown. Freshly implanted arterial allografts were
found to be unsuitable as vascular substitutes [21] and
their early failure has been associated with a strong immu-
nological reaction [22]. However, our morphological and
immunohistochemical findings on explanted cryopreserved
arterial allografts, although limited by a small number of
patients and a rather short follow-up, demonstrate a rejec-
tion reaction similar to what is observed in left-sided cryo-
preserved heart valve allografts explanted from adult
patients. Despite the occasional presence of T lymphocytes,
this moderate inflammatory cell infiltration in arterial allo-
grafts, observed in this study, has been confirmed by Goffin
et al. [23]. Thus, the long-term outcome of arterial and heart
valve allografts implanted in adults may be quite similar,
rendering cryopreserved arterial allografts a more durable
vascular substitute than as freshly implanted arteries. This is
further supported by the preservation of the collagen skele-
ton which does not differ between our adult heart valve and
vascular allografts.
There are several limitations to this study: first, it is a
descriptive study, which does not quantify the degree of
inflammatory cell infiltration nor the amount of allograft
wall calcification. Thus, we were not able to determine a
relationship between cell rejection and propensity for allo-
graft calcification; second, due to the small number of
explanted allografts, comparison between pulmonary and
aortic allografts has not been possible; third, this morpho-
logical study was designed to detect differences in immu-
nological rejection of various allografts. The results
observed do not represent the actuarial survival of right-
sided allografts used in congenital heart surgery nor from
those used to treat acute infectious aortic endocarditis in
adults.
In conclusion, allografts from infants showed active T
lymphocyte mediated cellular rejection limiting the durabil-
ity of these right-sided allografts in the paediatric age group.
By contrast, heart valve and arterial allografts in adults are
subjected to a relatively weak humoral rejection. The addi-
tional preservation of the ground substance, which is com-
parable for cryopreserved heart valve and vascular
allografts expects similar long-term results for left-sided
heart valve and arterial allografts.
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Appendix A. Conference discussion
Dr U. Althaus (Bern, Switzerland): I think that is a very interesting
study with quite an important message. Your observation that right-sided
homografts explanted from a paediatric population showed clear signs of
an active cellular rejection might imply that some form of immunosup-
pressive therapy could be beneficial with regard to the long-term prognosis
of this particular subgroup of patients. In clinical practice, do you actually
use some kind of an immunosuppressive modality after implantation of a
cryopreserved homograft in a child?
Dr Vogt: No, we do not use immunosuppressive treatment. In these
patients, immunosuppression has been discussed by various groups, but, to
the best of my knowledge, has not yet been tried. I think it is difficult to
estimate complications and side effects of such a prolonged therapy. In
addition, the mortality rate for the exchange of degenerated right-sided
allografts has been 0%.
Dr M. O’Brien (Brisbane, Australia): Your excellent study does con-
firm the work of many who are demonstrating the immune response. I
wonder if you are really seeing the effect of age and not the difference
between right and left-sided implants. Some workers have shown that the
left-sided implants in the infant or young child also demonstrate a similar
immune response producing a much earlier failure. In fact in our hands, if
we look at the left-sided implants across the age bracket, the highest failure
is in that young child as opposed to the good durability in the older,
middle-aged adult. So I just wondered if you were just looking at the
effect of age. What is your opinion?
The second question I have is to do with viability. Would it be better to
have totally dead, non-viable valves for infants?
Dr Vogt: We do not have a fair number of left-sided allografts
explanted from the paediatric age group. Thus, we cannot compare
right-sided with left-sided allografts from infants only. Up to the age of
16 years, the morphological as well as immunohistochemical studies did
not reveal a difference with regard to rejection. We’ve found T-lympho-
cytes in all our allografts explanted from children.
There is some controversy about allograft viability. On the one hand,
viability may prolong durability, on the other hand, viability may provoke
a stronger rejection reaction, again limiting the durability of these allo-
grafts. This problem is not solved.
I know, Dr O’Brien, that you use early cryopreserved allografts sug-
gesting improved durability. However, we cannot determine the ischemia
time in our allografts since we use allografts from an European pool.
Dr O’Brien: I would just like to make one last comment on immuno-
suppression. We have got rats immunosuppressed with abdominal allograft
aorta valve implants. These are unlike rats and are compared with a rat
group that previously were not immunosuppressed. I think our immunol-
ogy department will get the answer to this and to use the model to decide
on the duration of immunosuppression that may be needed. I think these
very important answers will come out over the next year.
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Dr Z. Religa (Zabrze, Poland): Our clinical and experimental results
are totally different, maybe due to the fact that the ischemic time that we
accept is after 6 h. So what is the ischemic time of your homografts?
Dr Vogt: I cannot give you an exact answer. We explant allografts from
multiorgan donors with a very short warm ischemia time. They are imme-
diately stored in cold saline solution with a cold ischemia time of less than
24 h. As far as we get allografts from a European pool, I cannot answer
your question. However, a shorter period of cold ischemia time is not
proven to improve the long-term results of implanted allografts. We
believe that rejection phenomenon’s, as described, are more important
determining their outcome.
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